Literature DB >> 21424391

Recombinant synthesis of human ABCG2 expressed in the yeast Saccharomyces cerevisiae: an experimental methodological study.

Anna Jacobs1, Dana Emmert, Svenja Wieschrath, Christine A Hrycyna, Michael Wiese.   

Abstract

Human ABCG2 is an efflux protein belonging to the ATP-binding cassette transporter superfamily. It is expressed in the plasma membrane of different cell types performing various physiological functions. It is the most recently discovered MDR transporter and its structure and function are still not well understood. Thus, expression and functional reconstitution of the protein in different variants and from different sources are important steps for its further investigation. In this work we describe a recombinant synthesis of human ABCG2 R482G from S. cerevisiae. We expressed the human ABCG2 R482G variant in S. cerevisiae and purified the protein from total yeast membranes. Using a panel of sixteen detergents, we analyzed the efficiency of extraction of ABCG2 from membranes by SDS-PAGE and immunoblot analysis. Based on these results, three detergents were selected for further purification studies and two of them, n-octyl-β-D-glucopyranoside and n-dodecyl-β-D-maltopyranoside, yielded functional protein after reconstitution into liposomes. We show here the first example of purified and reconstituted ABCG2 expressed in S. cerevisiae retaining drug-stimulated ATPase activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424391     DOI: 10.1007/s10930-011-9321-5

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  50 in total

1.  Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.

Authors:  Ulla Henriksen; Jacob U Fog; Thomas Litman; Ulrik Gether
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

2.  Role of the breast cancer resistance protein (ABCG2) in drug transport.

Authors:  Qingcheng Mao; Jashvant D Unadkat
Journal:  AAPS J       Date:  2005-05-11       Impact factor: 4.009

3.  Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.

Authors:  Csilla Ozvegy; András Váradi; Balázs Sarkadi
Journal:  J Biol Chem       Date:  2002-10-08       Impact factor: 5.157

4.  Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis.

Authors:  Tavan Janvilisri; Henrietta Venter; Sanjay Shahi; Galya Reuter; Lekshmy Balakrishnan; Hendrik W van Veen
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

5.  Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.

Authors:  M Ishii; M Iwahana; I Mitsui; M Minami; S Imagawa; A Tohgo; A Ejima
Journal:  Anticancer Drugs       Date:  2000-06       Impact factor: 2.248

Review 6.  Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Authors:  L Austin Doyle; Douglas D Ross
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

7.  A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

Authors:  R Allikmets; L M Schriml; A Hutchinson; V Romano-Spica; M Dean
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

8.  Effect of cysteine mutagenesis on the function and disulfide bond formation of human ABCG2.

Authors:  Yang Liu; Youyun Yang; Jing Qi; Hui Peng; Jian-Ting Zhang
Journal:  J Pharmacol Exp Ther       Date:  2008-04-22       Impact factor: 4.030

9.  Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro.

Authors:  Caroline Henrike Storch; Robert Ehehalt; Walter Emil Haefeli; Johanna Weiss
Journal:  J Pharmacol Exp Ther       Date:  2007-07-24       Impact factor: 4.030

10.  Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.

Authors:  A Pál; D Méhn; E Molnár; S Gedey; P Mészáros; T Nagy; H Glavinas; T Janáky; O von Richter; G Báthori; L Szente; P Krajcsi
Journal:  J Pharmacol Exp Ther       Date:  2007-03-08       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.